Peter Krammer, MD Co-founder and President
Prof. Immunology at Heidelberg University, Scientific Expert
48 years Experience in Science Management:
Head of the Division of Immunogenetics at the DKFZ , Heidelberg, Germany, Speaker of the Tumorimmunology Program at the DKFZ, Co-Founder of APOGENIX Biotech Company, Speaker of the Helmholtz Alliance Immunotherapy of Cancer, Member of the Board of Directors NCT Heidelberg
Multiple scientific prizes (e.g Robert Koch, Kitasato Behring, Ernst Jung, German Cancer)
Bjoern Cochlovius, Co-founder and CEO
Mol. Biologist, Assoc.Prof., Scientist and Life Science Business Experrt
26 years Experience in Academia and Industry (R&D, Strategy, Business):
Head Dept. Recomb. Antibodies DKFZ; Head R&D Affitech; CEO OnTarget Therapeutics; Director Business Dev. Roche; Interim-CEO Ciliatech; Head Oncology Otsuka NP; Head Development Japan-Asia-Pacific Abbvie; Chairman of Sapreme (Utrecht, NLD), Chairman at Karolinska Development, Partner at Norasia Investment Holding, Hong Kong.
Heiko Weyd, Co-founder and CSO
Biochemist, Scientist and R&D Expert
20 years of Experience in Research with Focus on the Annexin Checkpoint System:
Head of the Annexin Immunoregulation Group, German Cancer Research Center DKFZ, Heidelberg – Development of Purification Methods, Activity Assays and Establishment of in vivo Mouse Models (Tumor, Allergy, and others).
Peter Willinger, CFO
Life Science Finance and Business Expert
22 years of Experience in Biotech industry:
CFO of several private and publically listed Biotech companies, LION bioscience AG, SYGNIS Pharma AG, Apogenix AG, Transaction experience in IPO, M&A, Fundraising, Management experience in HR, legal/IP, quality assurance, investor/public relations, and corporate development.
Xin Liu, Co-founder
Mol. Biologist, Life Science Business and Investment Expert
>20 years in Pharma industry and Venture Capital/Private Equity:
Master thesis with Prof. Rajewsky (Cologne University). Senior positions in corporate M&A, Business Development and Marketing/sales with GSK, Roche and Eli Lilly. Co-founded or seed founded more than 15 Biotech start-ups. Former partner at Eight Roads VC. Formerly managing Director and head of GPC Capital, China. Board Director at Tasly Pharma and Silexon.